Evercore ISI Group analyst Umer Raffat initiates coverage on Legend Biotech (NASDAQ:LEGN) with a Outperform rating.
Keybanc Maintains Overweight on Twilio, Lowers Price Target to $77
Keybanc analyst Thomas Blakey maintains Twilio (NYSE:TWLO) with a Overweight and lowers the price target from $96 to $77.